These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 27224930)

  • 1. Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia.
    Bereczki E; Francis PT; Howlett D; Pereira JB; Höglund K; Bogstedt A; Cedazo-Minguez A; Baek JH; Hortobágyi T; Attems J; Ballard C; Aarsland D
    Alzheimers Dement; 2016 Nov; 12(11):1149-1158. PubMed ID: 27224930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of ZnT3 and PSD95 protein levels in Lewy body dementias and Alzheimer's disease: association with cognitive impairment.
    Whitfield DR; Vallortigara J; Alghamdi A; Howlett D; Hortobágyi T; Johnson M; Attems J; Newhouse S; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Francis PT
    Neurobiol Aging; 2014 Dec; 35(12):2836-2844. PubMed ID: 25104558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body Dementia.
    Alghamdi A; Vallortigara J; Howlett DR; Broadstock M; Hortobágyi T; Ballard C; Thomas AJ; O'Brien JT; Aarsland D; Attems J; Francis PT; Whitfield DR
    J Alzheimers Dis; 2017; 57(2):373-386. PubMed ID: 28269775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRS in mild cognitive impairment: early differentiation of dementia with Lewy bodies and Alzheimer's disease.
    Zhang B; Ferman TJ; Boeve BF; Smith GE; Maroney-Smith M; Spychalla AJ; Knopman DS; Jack CR; Petersen RC; Kantarci K
    J Neuroimaging; 2015; 25(2):269-274. PubMed ID: 25039916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose hypometabolism and neuropathological correlates in brains of dementia with Lewy bodies.
    Higuchi M; Tashiro M; Arai H; Okamura N; Hara S; Higuchi S; Itoh M; Shin RW; Trojanowski JQ; Sasaki H
    Exp Neurol; 2000 Apr; 162(2):247-56. PubMed ID: 10739631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anxiety symptoms are quantitatively and qualitatively different in dementia with Lewy bodies than in Alzheimer's disease in the years preceding clinical diagnosis.
    Segers K; Benoit F; Meyts JM; Surquin M
    Psychogeriatrics; 2020 May; 20(3):242-246. PubMed ID: 31782249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.
    Bereczki E; Branca RM; Francis PT; Pereira JB; Baek JH; Hortobágyi T; Winblad B; Ballard C; Lehtiö J; Aarsland D
    Brain; 2018 Feb; 141(2):582-595. PubMed ID: 29324989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Network proteomics of the Lewy body dementia brain reveals presynaptic signatures distinct from Alzheimer's disease.
    Shantaraman A; Dammer EB; Ugochukwu O; Duong DM; Yin L; Carter EK; Gearing M; Chen-Plotkin A; Lee EB; Trojanowski JQ; Bennett DA; Lah JJ; Levey AI; Seyfried NT; Higginbotham L
    Mol Neurodegener; 2024 Aug; 19(1):60. PubMed ID: 39107789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and multimodal biomarker correlates of ADNI neuropathological findings.
    Toledo JB; Cairns NJ; Da X; Chen K; Carter D; Fleisher A; Householder E; Ayutyanont N; Roontiva A; Bauer RJ; Eisen P; Shaw LM; Davatzikos C; Weiner MW; Reiman EM; Morris JC; Trojanowski JQ;
    Acta Neuropathol Commun; 2013 Oct; 1():65. PubMed ID: 24252435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term cognitive outcome of Alzheimer's disease and dementia with Lewy bodies: dual disease is worse.
    Blanc F; Mahmoudi R; Jonveaux T; Galmiche J; Chopard G; Cretin B; Demuynck C; Martin-Hunyadi C; Philippi N; Sellal F; Michel JM; Tio G; Stackfleth M; Vandel P; Magnin E; Novella JL; Kaltenbach G; Benetos A; Sauleau EA
    Alzheimers Res Ther; 2017 Jun; 9(1):47. PubMed ID: 28655337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation and differential diagnosis of dementia with Lewy bodies: a review.
    Morra LF; Donovick PJ
    Int J Geriatr Psychiatry; 2014 Jun; 29(6):569-76. PubMed ID: 24150834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional functional synchronizations in dementia with Lewy bodies and Alzheimer's disease.
    Peraza LR; Colloby SJ; Deboys L; O'Brien JT; Kaiser M; Taylor JP
    Int Psychogeriatr; 2016 Jul; 28(7):1143-51. PubMed ID: 26976496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive Deficits Distinguishing Mild Dementia with Lewy Bodies from Mild Alzheimer's Disease are Associated with Parkinsonism.
    Brønnick K; Breitve MH; Rongve A; Aarsland D
    J Alzheimers Dis; 2016 Jun; 53(4):1277-85. PubMed ID: 27372647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morphological substrates of mental dysfunction in Lewy body disease: an update.
    Jellinger KA
    J Neural Transm Suppl; 2000; 59():185-212. PubMed ID: 10961431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EEG comparisons in early Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease with dementia patients with a 2-year follow-up.
    Bonanni L; Thomas A; Tiraboschi P; Perfetti B; Varanese S; Onofrj M
    Brain; 2008 Mar; 131(Pt 3):690-705. PubMed ID: 18202105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneity in α-synuclein subtypes and their expression in cortical brain tissue lysates from Lewy body diseases and Alzheimer's disease.
    Vaikath NN; Erskine D; Morris CM; Majbour NK; Vekrellis K; Li JY; El-Agnaf OMA
    Neuropathol Appl Neurobiol; 2019 Oct; 45(6):597-608. PubMed ID: 30422353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Greater Variability in Cognitive Decline in Lewy Body Dementia Compared to Alzheimer's Disease.
    Giil LM; Aarsland D
    J Alzheimers Dis; 2020; 73(4):1321-1330. PubMed ID: 31903991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Alzheimer's Disease, Lewy Body and Vascular Co-Pathologies on Clinical Transition to Dementia in a National Autopsy Cohort.
    Pillai JA; Butler RS; Bonner-Jackson A; Leverenz JB
    Dement Geriatr Cogn Disord; 2016; 42(1-2):106-16. PubMed ID: 27623397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.